Total Payments
$2,427
2024 Payments
$252.59
Companies
30
Transactions
169
Medicare Patients
5,724
Medicare Billing
$374,805
Payment Breakdown by Category
Food & Beverage$2,427 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,427 | 169 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $387.86 | 31 | $0 (2024) |
| Novo Nordisk Inc | $294.67 | 20 | $0 (2024) |
| PFIZER INC. | $224.58 | 16 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $204.81 | 15 | $0 (2020) |
| GlaxoSmithKline, LLC. | $155.86 | 10 | $0 (2024) |
| Astellas Pharma US Inc | $141.38 | 8 | $0 (2024) |
| Amarin Pharma Inc. | $124.92 | 9 | $0 (2021) |
| ABBVIE INC. | $117.65 | 8 | $0 (2024) |
| Lilly USA, LLC | $93.03 | 7 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $65.56 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $252.59 | 15 | Novo Nordisk Inc ($65.42) |
| 2023 | $185.52 | 11 | GlaxoSmithKline, LLC. ($66.94) |
| 2021 | $28.70 | 2 | Amarin Pharma Inc. ($14.52) |
| 2020 | $341.10 | 25 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($68.38) |
| 2019 | $394.15 | 30 | Merck Sharp & Dohme Corporation ($59.20) |
| 2018 | $606.58 | 45 | Merck Sharp & Dohme Corporation ($119.25) |
| 2017 | $618.74 | 41 | Merck Sharp & Dohme Corporation ($152.23) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Biological | ||||||
| 06/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: PAIN | ||||||
| 04/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: VACCINE | ||||||
| 04/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: PAIN | ||||||
| 03/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes Care | ||||||
| 02/21/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Vaccines | ||||||
| 11/07/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2023 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological), Fluad Quadrivalent | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Vaccines | ||||||
| 07/26/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Diabetes Care | ||||||
| 05/15/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), VAXNEUVANCE | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: VACCINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,392 | 1,575 | $292,577 | $76,349 |
| 2022 | 13 | 1,399 | 1,620 | $287,581 | $82,603 |
| 2021 | 15 | 1,292 | 1,456 | $229,807 | $112,266 |
| 2020 | 16 | 1,641 | 1,851 | $178,062 | $103,588 |
Total Patients
5,724
Total Services
6,502
Medicare Billing
$374,805
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 333 | $68,598 | $14,959 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 264 | $76,296 | $12,682 | 16.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 245 | 245 | $72,520 | $12,373 | 17.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 155 | 155 | $20,150 | $11,136 | 55.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 41 | 41 | $10,906 | $5,363 | 49.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 157 | 157 | $10,676 | $5,333 | 50.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 236 | 236 | $10,148 | $4,914 | 48.4% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 14 | 14 | $6,748 | $3,540 | 52.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $5,655 | $2,037 | 36.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 24 | 30 | $6,150 | $1,915 | 31.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 55 | 55 | $3,740 | $1,868 | 50.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 18 | $594.00 | $167.18 | 28.1% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 12 | 12 | $396.00 | $64.30 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 230 | 377 | $72,412 | $18,110 | 25.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 236 | 236 | $66,830 | $13,509 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 198 | 259 | $70,819 | $12,842 | 18.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 158 | 162 | $20,804 | $11,077 | 53.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 42 | 42 | $10,578 | $5,531 | 52.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 160 | 164 | $10,968 | $5,531 | 50.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 218 | 218 | $9,216 | $4,606 | 50.0% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 16 | 16 | $7,196 | $4,007 | 55.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 32 | 37 | $6,609 | $2,543 | 38.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $5,627 | $2,349 | 41.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 56 | 56 | $3,555 | $1,899 | 53.4% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 13 | 13 | $2,082 | $299.49 | 14.4% |
About Dr. James Hakim, MD
Dr. James Hakim, MD is a Internal Medicine healthcare provider based in New Providence, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457411019.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Hakim, MD has received a total of $2,427 in payments from pharmaceutical and medical device companies, with $252.59 received in 2024. These payments were reported across 169 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,427).
As a Medicare-enrolled provider, Hakim has provided services to 5,724 Medicare beneficiaries, totaling 6,502 services with total Medicare billing of $374,805. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location New Providence, NJ
- Active Since 12/12/2006
- Last Updated 02/18/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1457411019
Products in Payments
- XIFAXAN (Drug) $159.59
- Ozempic (Drug) $150.78
- Vascepa (Drug) $124.92
- JANUVIA (Drug) $120.74
- PNEUMOVAX 23 (Biological) $92.11
- AREXVY (Drug) $83.35
- CHANTIX (Drug) $80.44
- Myrbetriq (Drug) $78.94
- VIAGRA (Drug) $66.17
- UBRELVY (Drug) $63.29
- SHINGRIX (Biological) $57.68
- NOXAFIL (Drug) $56.63
- XARELTO (Drug) $56.46
- UCERIS (Drug) $55.73
- LINZESS (Drug) $51.25
- Victoza (Drug) $50.25
- FLUZONE HIGH-DOSE (Drug) $45.79
- FARXIGA (Drug) $44.15
- JARDIANCE (Drug) $41.27
- VESICARE (Drug) $41.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in New Providence
Dr. Paul Zukoff, Md, MD
Internal Medicine — Payments: $2,831
Internal Medicine $2,831
Dr. Sushmita Srivastav, Md, MD
Internal Medicine — Payments: $176.77
Internal Medicine $176.77
Dr. Kavita Kewalramani, M.d, M.D
Internal Medicine — Payments: $56.76
Internal Medicine $56.76
Dr. Khimya Vaswani, Md, MD
Internal Medicine
Internal Medicine